Marianne P. Allen

Array ( [id] => 1602523 [patent_doc_number] => 06432702 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Mammalian growth factor nucleic acids, vectors, and host cells' [patent_app_type] => B1 [patent_app_number] => 08/478486 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 11343 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432702.pdf [firstpage_image] =>[orig_patent_app_number] => 08478486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933238 [patent_doc_number] => 05972645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Flea serine protease nucleic acid molecules' [patent_app_type] => 1 [patent_app_number] => 8/484211 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 37375 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 290 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972645.pdf [firstpage_image] =>[orig_patent_app_number] => 484211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006881 [patent_doc_number] => 05962257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Flea aminopeptidase nucleic acid molecules' [patent_app_type] => 1 [patent_app_number] => 8/482130 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 37394 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962257.pdf [firstpage_image] =>[orig_patent_app_number] => 482130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7079321 [patent_doc_number] => 20010041786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'STABILIZED ACYLATED INSULIN FORMULATIONS' [patent_app_type] => new [patent_app_number] => 08/484542 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3547 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041786.pdf [firstpage_image] =>[orig_patent_app_number] => 08484542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129873 [patent_doc_number] => 06146870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Flea protease proteins' [patent_app_type] => 1 [patent_app_number] => 8/485443 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 38035 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146870.pdf [firstpage_image] =>[orig_patent_app_number] => 485443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4025361 [patent_doc_number] => 05883071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Mammalian growth factor' [patent_app_type] => 1 [patent_app_number] => 8/478485 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 6108 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883071.pdf [firstpage_image] =>[orig_patent_app_number] => 478485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4222068 [patent_doc_number] => 06040431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Single chain analogs of the TGF-.beta. superfamily (morphons)' [patent_app_type] => 1 [patent_app_number] => 8/478097 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 39 [patent_no_of_words] => 38431 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040431.pdf [firstpage_image] =>[orig_patent_app_number] => 478097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098615 [patent_doc_number] => 06096866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Netrins' [patent_app_type] => 1 [patent_app_number] => 8/650599 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6427 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096866.pdf [firstpage_image] =>[orig_patent_app_number] => 650599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3758587 [patent_doc_number] => 05843749 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Ehk and Ror tyrosine kinases' [patent_app_type] => 1 [patent_app_number] => 8/469537 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 114 [patent_no_of_words] => 34641 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843749.pdf [firstpage_image] =>[orig_patent_app_number] => 469537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059623 [patent_doc_number] => 06007820 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Purification and characterization of MHC-peptide complexes useful in ameliorating autoimmunity' [patent_app_type] => 1 [patent_app_number] => 8/470397 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 17050 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007820.pdf [firstpage_image] =>[orig_patent_app_number] => 470397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868441 [patent_doc_number] => 05763214 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Fibroblast growth factor 11' [patent_app_type] => 1 [patent_app_number] => 8/464590 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14000 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763214.pdf [firstpage_image] =>[orig_patent_app_number] => 464590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3875862 [patent_doc_number] => 05728546 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Fibroblast growth factor 13' [patent_app_type] => 1 [patent_app_number] => 8/462965 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13098 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728546.pdf [firstpage_image] =>[orig_patent_app_number] => 462965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320969 [patent_doc_number] => 06331414 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Preparation of human IGF via recombinant DNA technology' [patent_app_type] => 1 [patent_app_number] => 8/464255 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 16284 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331414.pdf [firstpage_image] =>[orig_patent_app_number] => 464255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324141 [patent_doc_number] => 06331609 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Preparation of human IGF via recombinant DNA technology' [patent_app_type] => 1 [patent_app_number] => 8/464361 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 14754 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331609.pdf [firstpage_image] =>[orig_patent_app_number] => 464361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770697 [patent_doc_number] => 05807705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, DNA encoding same and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/461027 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4253 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807705.pdf [firstpage_image] =>[orig_patent_app_number] => 461027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292225 [patent_doc_number] => 06197548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Transformed Pichia expressing the pertactin antigen' [patent_app_type] => 1 [patent_app_number] => 8/460269 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 5143 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197548.pdf [firstpage_image] =>[orig_patent_app_number] => 460269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3997839 [patent_doc_number] => 05858655 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Method for diagnosing neoplasia by detecting expression of PRAD1 cyclin' [patent_app_type] => 1 [patent_app_number] => 8/460694 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 7487 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858655.pdf [firstpage_image] =>[orig_patent_app_number] => 460694 [rel_patent_id] =>[rel_patent_doc_number] =>)